Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wald

Showing results (91-100 of 550) with videos related to

Pageof 55
Sort By:
Prenatal Diagnosis|October 8, 1997
Combining ultrasound and biochemistry in first-trimester screening for Down's syndromeN J Wald, A K Hackshaw
The American Journal of Medicine|September 6, 2016
The Need to Interpret the Results of a Clinical Trial in the Context of Other EvidenceNicholas J Wald, Joan K Morris
Prenatal Diagnosis|February 17, 2001
Repeat testing in antenatal screening for Down syndrome using dimeric inhibin-A in combination with other maternal serum markersA K Hackshaw, N J Wald
The American Journal of Clinical Nutrition|September 1, 1990
Trends in individual consumption of dietary fat in the United States, 1920-1984A M Stephen, N J Wald
Prenatal Diagnosis|October 27, 2011
An audit of the detection of trisomy 18 in prenatal screening for Down syndrome using the Combined testWayne J Huttly, Nicholas J Wald
European Heart Journal|June 5, 2012
Personalized medicine: hope or hypeNicholas J Wald, Joan K Morris
Journal of Medical Screening|August 18, 2018
Conflating screening detection rates with the uptake of further testing: A potential source of confusionNicholas J Wald Editor, Robert Old
Prenatal Diagnosis|August 1, 1994
Maternal serum free alpha-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndromeN J Wald, J W Densem
Journal of Medical Screening|April 1, 1994
Choice of serum markers in antenatal screening for Down's syndromeN J Wald, H C Watt
Lancet (London, England)|April 29, 1995
Adipose tissue trans fatty acids and coronary heart diseaseM R Law, N J Wald
Pageof 55

Showing results (91-100 of 550) with videos related to

Sort By:
Pageof 55
Prenatal Diagnosis|October 8, 1997
Combining ultrasound and biochemistry in first-trimester screening for Down's syndromeN J Wald, A K Hackshaw
The American Journal of Medicine|September 6, 2016
The Need to Interpret the Results of a Clinical Trial in the Context of Other EvidenceNicholas J Wald, Joan K Morris
Prenatal Diagnosis|February 17, 2001
Repeat testing in antenatal screening for Down syndrome using dimeric inhibin-A in combination with other maternal serum markersA K Hackshaw, N J Wald
The American Journal of Clinical Nutrition|September 1, 1990
Trends in individual consumption of dietary fat in the United States, 1920-1984A M Stephen, N J Wald
Prenatal Diagnosis|October 27, 2011
An audit of the detection of trisomy 18 in prenatal screening for Down syndrome using the Combined testWayne J Huttly, Nicholas J Wald
European Heart Journal|June 5, 2012
Personalized medicine: hope or hypeNicholas J Wald, Joan K Morris
Journal of Medical Screening|August 18, 2018
Conflating screening detection rates with the uptake of further testing: A potential source of confusionNicholas J Wald Editor, Robert Old
Prenatal Diagnosis|August 1, 1994
Maternal serum free alpha-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndromeN J Wald, J W Densem
Journal of Medical Screening|April 1, 1994
Choice of serum markers in antenatal screening for Down's syndromeN J Wald, H C Watt
Lancet (London, England)|April 29, 1995
Adipose tissue trans fatty acids and coronary heart diseaseM R Law, N J Wald
Pageof 55